ad image

Sysmex Inostics

1 / 1
Sysmex Inostics
Oncology

Sysmex Inostics OncoBEAM™ Circulating Tumor DNA Technology Demonstrates Superior Response Prediction for Advanced Pancreatic Cancer over Standard-of-care Protein Biomarkers

Sysmex Inostics

PR-M11-18-NI-030Nov 08, 2018
Sysmex Inostics
Biopsy

Sysmex Inostics' OncoBEAM™ Liquid Biopsy Technology Demonstrates Utility for Clinical Management of Melanoma Patients Undergoing Treatment With Targeted Therapy and Immune Checkpoint Inhibitors

Sysmex Inostics

PR-M10-18-NI-061Oct 18, 2018
1 / 1